Lupin will gain semi-exclusive co-marketing rights for Zydus’ semaglutide injection in India under Semanext and Livarise, while Zydus retains its brands Semaglyn, Mashema and Alterme. Managing ...
Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat. Ganorkar added, "Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on ...
March 17 (Reuters) - Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply deal on Tuesday to co‑market semaglutide injections in the country ahead of the ingredient's ...
Hosted on MSN
Explained: Why skin boosters and filler injections fall outside India's cosmetic law, according to CDSCO
India’s Central Drugs Standard Control Organisation (CDSCO) has stated that cosmetic products are not permitted to be used through injections. It has warned that such practices violate provisions of ...
Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...
Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India. New Delhi wellness clinic Klarity Skin Clinic ...
The logo of Lupin is seen on the facade of its pharmaceutical plant in Verna, in the western state of Goa, India, June 9, 2017. Picture taken June 9, 2017. REUTERS/Danish Siddiqui March 17 (Reuters) - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results